top of page

Publications

Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice

6 January 2016

Journal of Asthma and Allergy

David Price, Andrew M Wilson, Alison Chisholm, Anna Rigazio, Anne Burden, Michael Thomas, Christine King

Inhaled corticosteroid dose-response on blood eosinophils in asthma – Authors’ reply

31 December 2015

The Lancet Respiratory Medicine

David Price, Ian D Pavord, Mike Thomas, Christopher J Corrigan, Andrew M Wilson, Elizabeth V Hillyer, Marjan Kerkhof

Concept review of dry powder inhalers: correct interpretation of published data

1 December 2015

Multidisciplinary Respiratory Medicine

David Price, Henry Chrystyn

Predicting frequent COPD exacerbations using primary care data

8 November 2015

International Journal of Chronic Obstructive Pulmonary Disease

Marjan Kerkhof, Daryl Freeman, Rupert Jones, Alison Chisholm, David Price, Respiratory Effectiveness Group

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study

18 October 2015

The Lancet Respiratory Medicine

David Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew M Wilson, Mary Buatti Small, Gokul Gopalan, Valerie L Ashton, Anne Burden, Elizabeth V Hillyer, Marjan Kerkhof, Ian D Pavord

Current controversies and challenges in allergic rhinitis management

28 August 2015

Expert Review of Clinical Immunology

David Price, Pete Smith, Peter Hellings, Nikos Papadopoulos, Wytske Fokkens, Antonella Muraro, Ruth Murray, Alison Chisholm, Pascal Demoly, Glenis Scadding, Joaquim Mullol, Phil Lieberman, Claus Bachert, Ralph Mösges, Dermot Ryan, Jean Bousquet

Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study

10 June 2015

NPJ Primary Care Respiratory Medicine

Steve W Turner, Kathryn Richardson, Annie Burden, Mike Thomas, Clare Murray, David Price

Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma

31 May 2015

Annals of the American Thoracic Society

Elliot Israel, Nicolas Roche, Richard J. Martin, Gene Colice, Paul M. Dorinsky, Dirkje S. Postma, Theresa W. Guilbert, Willem M. C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Anne Burden, Julie von Ziegenweidt, Victoria Thomas, David Price

Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma

28 May 2015

Journal of Allergy and Clinical Immunology: In Practice

Willem M.C. van Aalderen, Jonathan Grigg, Theresa W. Guilbert, Nicolas Roche, Elliot Israel, Richard J. Martin, Gene Colice, Dirkje S. Postma, Elizabeth V. Hillyer, Anne Burden, Victoria Thomas, Julie von Ziegenweidti, David Price

Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma

14 April 2015

American Journal of Respiratory and Critical Care Medicine

Nicolas Roche, Dirkje S. Postma, Gene Colice, Anne Burden, Theresa W. Guilbert, Elliot Israel, Richard J. Martin, Willem M. C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Julie von Ziegenweidt, David Price

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

13 January 2015

Journal of Asthma and Allergy

David Price, Alan Kaplan, Rupert Jones, Daryl Freeman, Anne Burden, Shuna Gould, Julie von Ziegenweidt, Muzammil Ali, Christine King, Mike Thomas

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

16 October 2014

International Journal of Chronic Obstructive Pulmonary Disease

Dirkje S Postma, Nicolas Roche, Gene Colice, Elliot Israel, Richard J Martin, Willem MC van Aalderen, Jonathan Grigg, Anne Burden, Elizabeth V Hillyer, Julie von Ziegenweidt, Gokul Gopalan, David Price

Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study

8 October 2014

NPJ Primary Care Respiratory Medicine

Richard J Martin, David Price, Nicolas Roche, Elliot Israel, Willem MC van Aalderen, Jonathan Grigg, Dirkje S Postma, Theresa W Guilbert, Elizabeth V Hillyer, Anne Burden, Julie von Ziegenweidt, Gene Colice

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

6 September 2014

International Journal of Chronic Obstructive Pulmonary Disease

Claire Brockwell, Sundari Ampikaipakan, Darren W Sexton, David Price, Daryl Freeman, Mike Thomas, Muzammil Ali, Andrew M Wilson

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

26 August 2014

International Journal of Chronic Obstructive Pulmonary Disease

David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, Katsiaryna Bichel

Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma

5 May 2014

Expert Review of Respiratory Medicine

David Price, Elizabeth V Hillyer

Switching patients from other inhaled corticosteroid devices to the Easyhaler®: historical, matched-cohort study of real-life asthma patients

9 April 2014

Journal of Asthma and Allergy

David Price, Vicky Thomas, Julie von Ziegenweidt, Shuna Gould, Catherine Hutton, Christine King

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study

15 January 2014

BMC Pulmonary Medicine

Henry Chrystyn, David Price, Mathieu Molimard, John Haughney, Sinthia Bosnic-Anticevich, Federico Lavorini, John Efthimiou, Dawn Shan, Erika Sims, Anne Burden, Catherine Hutton, Nicolas Roche

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care

6 November 2013

Clinical and Translational Allergy

David Price, Dermot Ryan, Annie Burden, Julie Von Ziegenweidt, Shuna Gould, Daryl Freeman, Kevin Gruffydd-Jones, Anne Copland, Clifford Godley, Alison Chisholm, Mike Thomas

Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients

1 November 2013

Primary Care Respiratory Journal

David Price, Iain Small, John Haughney, Dermot Ryan, Kevin Gruffydd-Jones, Federico Lavorini, Tim Harris, Annie Burden, Jeremy Brockman, Christine King, Alberto Papi

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
thumbnail_IMS-white-ISO_9001_ISO_27001-removebg-preview.png

Certificate
No: 385342022

GBC Accreditation
2025 Ecovadis.png
Designer_edited.png
Follow Us
  • Instagram
  • Threads
  • LinkedIn
  • X
Contact Us
Email:
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
OPRI Singapore
22 SIN MING LANE #06-76, MIDVIEW CITY,(573969) 
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
OPRI 2025 All Rights Reserved
bottom of page